Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKER OTCMKTS:BGMD OTCMKTS:FPMI OTCMKTS:RGDXQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKERAkers Biosciences$0.12-7.4%$3.56$1.65▼$6.97$1.95M0.3769,876 shs9.00 million shsBGMDBG Medicine$0.00$0.00▼$0.00N/A2.52N/AN/AFPMIFluoroPharma Medical$0.00$0.00▼$0.00N/AN/AN/AN/ARGDXQResponse Genetics$0.00$0.00▼$0.00N/AN/AN/AN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKERAkers Biosciences+5.25%+9.07%-25.27%-50.95%-92.99%BGMDBG Medicine0.00%0.00%0.00%0.00%0.00%FPMIFluoroPharma Medical0.00%0.00%0.00%0.00%0.00%RGDXQResponse Genetics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKERAkers BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ABGMDBG MedicineN/AN/AN/AN/AN/AN/AN/AN/AFPMIFluoroPharma MedicalN/AN/AN/AN/AN/AN/AN/AN/ARGDXQResponse GeneticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKERAkers Biosciences 0.00N/AN/AN/ABGMDBG Medicine 0.00N/AN/AN/AFPMIFluoroPharma Medical 0.00N/AN/AN/ARGDXQResponse Genetics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKERAkers Biosciences$1.58M1.23N/AN/A$5.38 per share0.02BGMDBG MedicineN/AN/AN/AN/AN/AN/AFPMIFluoroPharma MedicalN/AN/AN/AN/AN/AN/ARGDXQResponse GeneticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKERAkers Biosciences-$3.89MN/A0.00∞N/AN/A-87.42%-73.31%N/ABGMDBG MedicineN/AN/A0.00N/AN/AN/AN/AN/AN/AFPMIFluoroPharma MedicalN/AN/A0.00N/AN/AN/AN/AN/AN/ARGDXQResponse GeneticsN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKERAkers BiosciencesN/AN/AN/AN/AN/ABGMDBG MedicineN/AN/AN/AN/AN/AFPMIFluoroPharma MedicalN/AN/AN/AN/AN/ARGDXQResponse GeneticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKERAkers BiosciencesN/A9.229.22BGMDBG MedicineN/AN/AN/AFPMIFluoroPharma MedicalN/AN/AN/ARGDXQResponse GeneticsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKERAkers Biosciences5.52%BGMDBG MedicineN/AFPMIFluoroPharma MedicalN/ARGDXQResponse GeneticsN/AInsider OwnershipCompanyInsider OwnershipAKERAkers Biosciences0.29%BGMDBG Medicine6.50%FPMIFluoroPharma Medical36.90%RGDXQResponse Genetics4.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKERAkers Biosciences416.65 millionN/ANot OptionableBGMDBG Medicine5N/AN/ANot OptionableFPMIFluoroPharma Medical4N/AN/ANot OptionableRGDXQResponse Genetics100N/AN/ANot OptionableBGMD, FPMI, RGDXQ, and AKER HeadlinesRecent News About These CompaniesRGDXQ Response Genetics, Inc - Seeking AlphaJuly 2, 2025 | seekingalpha.comNew framework enhances genetic prediction of drug response and side effectsDecember 5, 2024 | msn.comGenetic variation enhances cancer drug sensitivity in specific patient groups, study showsNovember 14, 2024 | msn.comRefugee response plansNovember 14, 2024 | unhcr.orgUDrug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 14, 2024 | msn.comNew cancer therapy strategy targets GLUT3 in regulatory T cells to supercharge anti-tumor immunityNovember 13, 2024 | msn.comCombining gene expression signature with liquid biopsy may improve response prediction to immunotherapyNovember 8, 2024 | medicalxpress.comMRGI to build a second West Circle commercial complexNovember 6, 2024 | finance.yahoo.comEpigenetic silencing of a DNA damage repair gene reveals a potential marker for pancreatic cancer treatmentNovember 6, 2024 | msn.comPrecision exercise medicine: understanding exercise response variabilityNovember 6, 2024 | bjsm.bmj.comBA 36-gene predictive score of anti-cancer drug resistance anticipates cancer therapy outcomesNovember 6, 2024 | uab.eduUWrightbus expands refurbishment division with acquisition of GB firm RGINovember 6, 2024 | msn.comBetween night and day: Research uncovers genetic basis for flies' circadian plasticityNovember 1, 2024 | msn.comRGI Airport increases security after receiving bomb threats in three aircraftsOctober 30, 2024 | telanganatoday.comTStudy uncovers six cancer susceptibility genesOctober 29, 2024 | msn.comIndigo Airlines Flights Alerted Amid Security Concerns at RGIOctober 28, 2024 | deccanchronicle.comDGenetic Variants and Escitalopram Response in MDDOctober 22, 2024 | physiciansweekly.comPHaryana Guv Dattratreya’s convoy collides at RGI airport, no injuries reportedOctober 20, 2024 | telanganatoday.comTA faster, more affordable technique for deciphering the genetics of diseaseOctober 19, 2024 | msn.comSurprise finding reveals the dual role of key neurodevelopmental gene FOXG1October 18, 2024 | msn.comBGMD, FPMI, RGDXQ, and AKER Company DescriptionsAkers Biosciences NASDAQ:AKERAkers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.BG Medicine OTCMKTS:BGMDBG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.FluoroPharma Medical OTCMKTS:FPMIFluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.Response Genetics OTCMKTS:RGDXQResponse Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group: Up 385%, Analysts Say It’s Still a Bargain BigBear.ai: Why a 90% Rally Could Be Just the Start Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Alphabet: Technical Momentum Is Starting to Turn Boeing's Rebound Is Well Underway—But Is It Too Late? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.